Journal article
PS1 -125 Assessment of Function and Quality of Life in a Phase II Multi-Institutional Clinical Trial of Fractionated Simultaneous In-Field Boost Radiotherapy for Patients with 1-2 Brain Metastases
Abstract
We examined functional outcomes and quality of life of whole brain radiotherapy (WBRT) with integrated fractionated stereotactic radiotherapy boost (FSRT) for brain metastases treatment. Methods Eighty seven people with 1-3 brain metastases were enrolled on this Phase II trial of WBRT (30Gy/10)+simultaneous FSRT, (60Gy/10). Results Mean (Min-Max) baseline KPS, Mini Mental Status Exam (MMSE) and FACT-BR quality of life were 83 (70-100), 28 …
Authors
Bauman G; Yartsev S; Roberge D; MacRae R; Roa W; Panet-Raymond V; Masucci L; Yaremko B; D’Souza D; Palma D
Journal
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 43, No. S4, pp. s8–s8
Publisher
Cambridge University Press (CUP)
Publication Date
10 2016
DOI
10.1017/cjn.2016.351
ISSN
0317-1671